Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection
- PMID: 10491487
Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection
Abstract
Objective: to determine the changes in acid output before and after eradication therapy in patients with duodenal ulcer associated with Helicobacter pylori infection.
Method: the subjects of this prospective study were 16 patients with acute duodenal ulcer at endoscopy and H. pylori infection determined by rapid urease test and histology. They were randomly assigned to receive treatment with pantoprazole 40 mg b.i.d., clarithromycin 500 mg b.i.d. and amoxicillin 1 g b.i.d. during 7 or 14 days. Endoscopic examination and biopsy were repeated 4 weeks after treatment ended. The changes in acid output before and after treatment were calculated by the morphometric quantification of parietal cell canaliculi from the gastric corpus. To this end 20 parietal cells from the medial glandular zone were selected and canalicular index was calculated, before and after eradication therapy, with a morphometric method based on automatic analysis of histological images.
Results: canalicular index was 26.4 +/- 1.4 (mean +/- standard error of the mean) before treatment, and 20.5 +/- 1 (p < 0.01) after therapy.
Conclusions: morphometric analysis showed a decrease in acid output in patients with duodenal ulcer associated with H. pylori infection 4 weeks after eradication therapy with clarithromycin, amoxicillin and pantoprazole.
Comment in
-
[Helicobacter pylori infection: a single microorganism with many consequences].Rev Esp Enferm Dig. 1999 Aug;91(8):537-40. Rev Esp Enferm Dig. 1999. PMID: 10576788 Spanish. No abstract available.
Similar articles
-
In treatment of active duodenal ulcer and Helicobacter pylori eradication.Hepatogastroenterology. 2003 Dec;50 Suppl 2:cccvi-cccviii. Hepatogastroenterology. 2003. PMID: 15244210 Clinical Trial.
-
Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients.Hepatogastroenterology. 1999 Jan-Feb;46(25):245-51. Hepatogastroenterology. 1999. PMID: 10228801 Clinical Trial.
-
The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.Curr Med Res Opin. 2004 Aug;20(8):1301-7. doi: 10.1185/030079904125004439. Curr Med Res Opin. 2004. PMID: 15324533 Clinical Trial.
-
Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.J Gastroenterol. 2005 Jan;40(1):94-7. doi: 10.1007/s00535-004-1499-2. J Gastroenterol. 2005. PMID: 15692795 Review.
-
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori].Rev Clin Esp. 1998 Oct;198(10):678-83. Rev Clin Esp. 1998. PMID: 9844458 Review. Spanish. No abstract available.
Cited by
-
Optimum duration of regimens for Helicobacter pylori eradication.Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2. Cochrane Database Syst Rev. 2013. PMID: 24338763 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical